India’s biggest medicine-making company, Sun Pharmaceutical Industries, is planning to acquire a US company called Organon.

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...

A worldwide leader in injectable drug administration will be the newest company to set up shop in Greenfield, and anticipates ...

Venture investors are adopting a more aggressive mindset heading into 2026, while Merck, Moderna and Summit are all ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.

Alliance brings together complementary strengths in commercialization strategy, cross-functional launch readiness, ...

Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools ...

Thermo Fisher Scientific's pharmaceutical services business has won a number of contracts to help its customers move ...

JW Pharmaceutical announced on the 19th that it has completed the registration of a U.S. patent for its hair loss treatment ...

A report on Monday said that Sun Pharma is evaluating a takeover of Organon & Co. in a transaction that could be valued at ...